Showing results (1-10 of 2,816) with videos related to
Sort By:
Pageof 282
Diabetologia|November 8, 2025
Is the NOD mouse a good model for type 1 diabetes?F Susan Wong, James A Pearson, Li WenJournal of Autoimmunity|September 26, 2015
The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetesJames A Pearson, F Susan Wong, Li WenHuman Vaccines & Immunotherapeutics|August 30, 2018
Modulation of the immune system by the gut microbiota in the development of type 1 diabetesJames A Pearson, Andrew Agriantonis, F Susan Wong, et al.Methods in Molecular Biology (Clifton, N.J.)|December 15, 2015
Identification of Islet Antigen-Specific CD8 T Cells Using MHCI-Peptide Tetramer Reagents in the Non Obese Diabetic (NOD) Mouse Model of Type 1 DiabetesJames A Pearson, F Susan WongFrontiers in Immunology|January 30, 2026
IL17-deficient NOD mice are protected from autoimmune diabetes due to decreased antigen presentation and T cell activationJames A Pearson, Yangyang Li, Juan Huang, et al.Diabetes|October 30, 2020
Differentiating MHC-Dependent and -Independent Mechanisms of Lymph Node Stromal Cell Regulation of Proinsulin-Specific CD8+ T Cells in Type 1 DiabetesTerri C Thayer, Joanne Davies, James A Pearson, et al.Proceedings of the National Academy of Sciences of the United States of America|August 26, 2015
NLRP3 deficiency protects from type 1 diabetes through the regulation of chemotaxis into the pancreatic isletsChangyun Hu, Heyuan Ding, Yangyang Li, et al.Current Molecular Medicine|February 1, 2003
The study of HLA class II and autoimmune diabetesF Susan Wong, Li WenAnnals of the New York Academy of Sciences|January 6, 2009
IFN-alpha can both protect against and promote the development of type 1 diabetesF Susan Wong, Li WenThe Review of Diabetic Studies : RDS|June 28, 2013
Type 1 diabetes therapy beyond T cell targeting: monocytes, B cells, and innate lymphocytesF Susan Wong, Li WenPageof 282